BioMarin Pharmaceutical

Rentabilidade por seis meses: -8.89%
Rendimento de dividendos: 0%
Setor: Healthcare

57.28 $

0 $ 0%
55.27 $
93.84 $

paper.min_max_per_year

Cronograma de promoção BioMarin Pharmaceutical

Parâmetros básicos

IPO date
1999-07-23
ISIN
US09061G1013
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0
Сайт

Nota

Subestimação
Nome Significado Nota
P/S 4.51 3
P/BV 2.28 6
P/E 30.16 5
Eficiência
Nome Significado Nota
ROA 6.17 2
ROE 8.05 3
ROIC 0.79 1
Dividendos
Nome Significado Nota
Rendimento de dividendos 0 0
DSI 0 0
Crescimento médio dos dividendos 0 0
Obrigação
Nome Significado Nota
Debt/EBITDA 0.9265 9
Debt/Ratio 0.0862 10
Debt/Equity 0.2352 10
Impulso de crescimento
Nome Significado Nota
Receita, % 53.44 7
Ebitda, % -11125.9 0
EPS, % -51.56 0

paper.price.prices

Preço Common.min. Common.max. Mudar paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 57.28 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 56.65 $ 0 $ 0 $ +1.11 % 0 % 0 %
common.calendar.number_days.30d 58.01 $ 0 $ 0 $ -1.26 % 0 % 0 %
common.calendar.number_days.90d 59.43 $ 55.27 $ 63.69 $ -3.62 % 0 % 0 %
common.calendar.number_days.180d 62.87 $ 55.27 $ 72.83 $ -8.89 % 0 % 0 %
common.calendar.number_days.1y 90.46 $ 55.27 $ 93.84 $ -36.68 % 0 % 0 %
common.calendar.number_days.3y 89.02 $ 55.27 $ 117.27 $ -35.65 % 0 % 0 %
common.calendar.number_days.5y 78.74 $ 55.27 $ 122.04 $ -27.25 % 0 % 0 %
common.calendar.number_days.10y 81.38 $ 55.27 $ 143.78 $ -29.61 % 0 % 0 %
common.calendar.number_days.ytd 61.58 $ 55.27 $ 72.83 $ -6.98 % 0 % 0 %

Negociação de informações privilegiadas

Principais proprietários

Contido em ETF

ETF
Compartilhar, %
Rentabilidade para o ano, %
Comissão, %
VictoryShares Nasdaq Next 50 ETF 1.38305 4.94 0.18
iShares Evolved U.S. Innovative Healthcare ETF 1.35 0.000586 0.18
Future Tech ETF 1.30612 479.5 0.35
Principal Healthcare Innovators ETF 1.30612 -3.92 0.35
IQ Engender Equality ETF 1.03522 3.37 0.45
GraniteShares XOUT U.S. Large Cap ETF 0.86381 -24.16 0.60
Syntax Stratified MidCap ETF 0.34133 -0.3413 0.35
iShares Morningstar Mid-Cap Growth ETF 0.24673 450.65 0.06
iShares Morningstar Mid-Cap ETF 0.12333 245.03 0.04
iShares Morningstar Large-Cap Growth ETF 0.05463 245.22 0.04
iShares Morningstar Large-Cap ETF 0.0266 186.3 0.03
Columbia U.S. ESG Equity Income ETF 0.02348 -4.51 0.35
0,67131,840,25

Empresas semelhantes



Gestão da empresa

Supervisor Cargo Pagamento Ano de nascimento
Mr. Brian R. Mueller CFO & Executive VP 1.15M 1974 (51 ano)
Mr. George Eric Davis Executive VP, Chief Legal Officer, General Counsel & Secretary 1.23M 1971 (54 ano)
Ms. Erin Burkhart Group VP & Chief Accounting Officer N/A 1979 (46 anos)
Mr. Alexander Hardy President, CEO & Director N/A 1969 (56 anos)
Dr. C. Greg Guyer Ph.D. Executive VP & CTO 1962 (63 ano)
Dr. Kevin Eggan Ph.D. Chief Scientific Officer & Senior VP of Research and Early Development
Traci McCarty Group Vice President of Investor Relations
Ms. Humaira Serajuddin Senior VP & Chief Marketing Officer
Ms. Amy Wireman Executive VP & Chief People Officer

Informações da empresa

Endereço: United States, San Rafael, 770 Lindaro Street - Abrir no google maps, Abrir mapas yandex
Site: http://www.biomarin.com

Sobre a empresa BioMarin Pharmaceutical

BioMarin Pharmaceutical Inc.  — американская биотехнологическая компания со штаб-квартирой в Сан-Рафаэле, Калифорния . У него есть офисы и помещения в США , Южной Америке , Азии и Европе . Основным направлением деятельности и исследованиями BioMarin является заместительная терапия ферментами (ФЗТ). BioMarin была первой компанией, которая предоставила терапевтические средства для лечения мукополисахаридоза типа I (MPS I), производя ларонидазу ( Aldurazyme , коммерциализируется Genzyme Corporation). BioMarin также была первой компанией, которая начала предлагать препараты для лечения фенилкетонурии.